Propel
Device Otolaryngology (Ear, Nose, Throat)
PDI M927700110
General payments
$857,180
Research payments
$419,966
Through program year 2024, $857,180 in general payments and $419,966 in research payments were reported against Propel (Otolaryngology (Ear, Nose, Throat)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $252,739 | 1,336 |
| 2023 | General | $400,877 | 2,262 |
| 2023 | Research | $10,063 | 8 |
| 2022 | General | $203,565 | 1,717 |
| 2022 | Research | $409,904 | 97 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
5,315 general · 105 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.